Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Santen Pharmaceutical Co., Ltd.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosis of open angle glaucoma (including primary open angle glaucoma, exfoliation glaucoma or pigmentary glaucoma) in one or both eyes or ocular hypertension for which the subject has been using prostaglandin or beta-adrenergic blocker IOP (intraocular pressure) -lowering drugs before the screening visit
Those who have signed the informed consent form
You may not be if
Women who are pregnant, nursing or planning pregnancy, or women of child-bearing potential who are not using a reliable method of contraception
Anterior chamber angle in either eye to be treated with the level \<2 according to Shaffer classification as measured by gonioscopy
Corneal disorder or other disease preventing reliable applanation tonometry in the treated eyes, including refractive surgery of ocular anterior segment)
Alcohol or drug abuse
Current participation in another clinical trial involving an investigational drug/device, or participation in such a trial within 30 days before Screening visit
Clareo Health | A Study of DE-111A on the Treatment of Open Angle Glaucoma or Ocular Hypertension
